INTRODUCTION: The use of syndromic surveillance has expanded from its initial purpose of bioterrorism detection. We present 6 use cases from New York City that demonstrate the value of syndromic surveillance for public health response and decision making across a broad range of health outcomes: synthetic cannabinoid drug use, heat-related illness, suspected meningococcal disease, medical needs after severe weather, asthma exacerbation after a building collapse, and Ebola-like illness in travelers returning from West Africa. MATERIALS AND METHODS: The New York City syndromic surveillance system receives data on patient visits from all emergency departments (EDs) in the city. The data are used to assign syndrome categories based on the chief complaint and discharge diagnosis, and analytic methods are used to monitor geographic and temporal trends and detect clusters. RESULTS: For all 6 use cases, syndromic surveillance using ED data provided actionable information. Syndromic surveillance helped detect a rise in synthetic cannabinoid-related ED visits, prompting a public health investigation and action. Surveillance of heat-related illness indicated increasing health effects of severe weather and led to more urgent public health messaging. Surveillance of meningitis-related ED visits helped identify unreported cases of culture-negative meningococcal disease. Syndromic surveillance also proved useful for assessing a surge of methadone-related ED visits after Superstorm Sandy, provided reassurance of no localized increases in asthma after a building collapse, and augmented traditional disease reporting during the West African Ebola outbreak. PRACTICE IMPLICATIONS: Sharing syndromic surveillance use cases can foster new ideas and build capacity for public health preparedness and response.
INTRODUCTION: The use of syndromic surveillance has expanded from its initial purpose of bioterrorism detection. We present 6 use cases from New York City that demonstrate the value of syndromic surveillance for public health response and decision making across a broad range of health outcomes: synthetic cannabinoid drug use, heat-related illness, suspected meningococcal disease, medical needs after severe weather, asthma exacerbation after a building collapse, and Ebola-like illness in travelers returning from West Africa. MATERIALS AND METHODS: The New York City syndromic surveillance system receives data on patient visits from all emergency departments (EDs) in the city. The data are used to assign syndrome categories based on the chief complaint and discharge diagnosis, and analytic methods are used to monitor geographic and temporal trends and detect clusters. RESULTS: For all 6 use cases, syndromic surveillance using ED data provided actionable information. Syndromic surveillance helped detect a rise in synthetic cannabinoid-related ED visits, prompting a public health investigation and action. Surveillance of heat-related illness indicated increasing health effects of severe weather and led to more urgent public health messaging. Surveillance of meningitis-related ED visits helped identify unreported cases of culture-negative meningococcal disease. Syndromic surveillance also proved useful for assessing a surge of methadone-related ED visits after Superstorm Sandy, provided reassurance of no localized increases in asthma after a building collapse, and augmented traditional disease reporting during the West African Ebola outbreak. PRACTICE IMPLICATIONS: Sharing syndromic surveillance use cases can foster new ideas and build capacity for public health preparedness and response.
Entities:
Keywords:
emergency department; syndromic surveillance; use cases
Authors: Melissa A Marx; Carla V Rodriguez; Jane Greenko; Debjani Das; Richard Heffernan; Adam M Karpati; Farzad Mostashari; Sharon Balter; Marcelle Layton; Don Weiss Journal: Am J Public Health Date: 2005-12-27 Impact factor: 9.308
Authors: Stella Tsai; Teresa Hamby; Alvin Chu; Jessie A Gleason; Gabrielle M Goodrow; Hui Gu; Edward Lifshitz; Jerald A Fagliano Journal: Disaster Med Public Health Prep Date: 2016-05-05 Impact factor: 1.385
Authors: Amy Ising; Scott Proescholdbell; Katherine J Harmon; Nidhi Sachdeva; Stephen W Marshall; Anna E Waller Journal: Inj Prev Date: 2016-04 Impact factor: 2.399
Authors: Donald R Olson; Richard T Heffernan; Marc Paladini; Kevin Konty; Don Weiss; Farzad Mostashari Journal: PLoS Med Date: 2007-08 Impact factor: 11.069
Authors: Zachary Faigen; Lana Deyneka; Amy Ising; Daniel Neill; Mike Conway; Geoffrey Fairchild; Julia Gunn; David Swenson; Ian Painter; Lauren Johnson; Chris Kiley; Laura Streichert; Howard Burkom Journal: Online J Public Health Inform Date: 2015-12-30
Authors: John Dunbar; Segaran Pillai; David Wunschel; Michael Dickens; Stephen A Morse; David Franz; Andrew Bartko; Jean Challacombe; Timothy Persons; Molly A Hughes; Steve R Blanke; Robin Holland; Janine Hutchison; Eric D Merkley; Katrina Campbell; Catherine S Branda; Shashi Sharma; Luther Lindler; Kevin Anderson; David Hodge Journal: Front Bioeng Biotechnol Date: 2018-10-23
Authors: Karen A Alroy; Aldo Crossa; Christine Dominianni; Jessica Sell; Katherine Bartley; Michael Sanderson; Steven Fernandez; Amber Levanon Seligson; Sung Woo Lim; Shu Meir Wang; Sarah E Dumas; Sharon E Perlman; Kevin Konty; Donald R Olson; L Hannah Gould; Sharon K Greene Journal: Clin Infect Dis Date: 2021-01-18 Impact factor: 9.079
Authors: Wan Yang; Sharon K Greene; Eric R Peterson; Wenhui Li; Robert Mathes; Laura Graf; Ramona Lall; Scott Hughes; Jade Wang; Anne Fine Journal: Sci Adv Date: 2022-01-28 Impact factor: 14.136
Authors: Giorgio Bagarella; Mauro Maistrello; Maddalena Minoja; Olivia Leoni; Francesco Bortolan; Danilo Cereda; Giovanni Corrao Journal: Int J Environ Res Public Health Date: 2022-09-28 Impact factor: 4.614
Authors: Paul Sandifer; Landon Knapp; Maureen Lichtveld; Ruth Manley; David Abramson; Rex Caffey; David Cochran; Tracy Collier; Kristie Ebi; Lawrence Engel; John Farrington; Melissa Finucane; Christine Hale; David Halpern; Emily Harville; Leslie Hart; Yulin Hswen; Barbara Kirkpatrick; Bruce McEwen; Glenn Morris; Raymond Orbach; Lawrence Palinkas; Melissa Partyka; Dwayne Porter; Aric A Prather; Teresa Rowles; Geoffrey Scott; Teresa Seeman; Helena Solo-Gabriele; Erik Svendsen; Terry Tincher; Juli Trtanj; Ann Hayward Walker; Rachel Yehuda; Fuyuen Yip; David Yoskowitz; Burton Singer Journal: Front Public Health Date: 2020-10-15